Abstract
The effects of IL-2 on brain development, function, and disease are the result of IL-2’s actions in the peripheral immune system and its intrinsic actions in the central nervous system (CNS). Determining whether, and under what circumstances (e.g., development, acute injury), these different actions of IL-2 are operative in the brain is essential to make significant advances in understanding the multifaceted affects of IL-2 on CNS function and disease, including psychiatric disorders. For several decades, there has been a great deal of speculation about the role of autoimmunity in brain disease. More recently, we have learned a great deal about the role of cytokines on neurobiological processes, and there have been many studies that have found peripheral immune alterations in patients with neurological and neuropsychiatric diseases. Despite a plethora of published literature, almost all of this data in humans is correlative and much of the basic research has understandably relied on simpler models (e.g., in vitro models). Good animal models such as our IL-2 knockout mouse model could provide valuable new insight into understanding how the complex biology of a cytokine such as IL-2 can have simultaneous, dynamic effects on multiple systems (e.g., regulating homeostasis in the brain and immune system, autoimmunity that can affect both systems). Animal models can also provide much needed new data elucidating neuroimmunological and autoimmune processes involved in brain development and disease. Such information may ultimately provide critical new insight into the role of brain cytokines and autoimmunity in prominent neurological and neuropsychiatric diseases (e.g., Alzheimer’s disease, autism, multiple sclerosis, schizophrenia).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Besedovsky, H.O., Del Rey, A., Klusman, I., Furukawa, H., Monge Arditi, G., Kabiersch, A. (1991) Cytokines as modulators of the hypothalamus-pituitary-adrenal axis, Journal of Steroid Biochemistry and Molecular Biology 40, 613–618.
Blalock, J.E. (1994) The syntax of immune-neuroendocrine communications, Immunology Today 15, 504–511.
Zalcman, S., Green-Johnson, J.M., Murray, L., Nance, D.M., Dyck, D., Anisman, H., Greenberg, A.H. (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2, and -6, Brain Res 643, 40–49.
Jankowsky, J., Patterson, P. (1999) Cytokine and growth factor involvement in long-term potentiation, Molecular and Cellular Neuroscience 14, 273–286.
Pugh, C.R., Kumagawa, K., Fleshner, M., Watkins, L.R., Maier, S.F., Rudy, J.W. (1998) Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning, Brain, behavior, and immunity 3, 212–29.
Laye, S., Parnet, P., Goujon, E., Dantzer, R. (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice, Brain research. Molecular brain research 27, 157–62.
Gibertini, M., Newton, C., Klein, T.W., Friedman, H. (1995) Legionella pneumophila-induced visual learning impairment reversed by anti-interleukin-1 beta, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 210, 7–11
Aubert A., Vega C., Dantzer R., Goodall, G. (1995) Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat, Brain, behavior, and immunity 9, 129–48.
Dantzer, R., Bluthe, R.M., Gheusi, G., Cremona, S., Laye, S., Parnet, P., Kelley, KW. (1998) Molecular basis of sickness behavior, Annals of the New York Academy of Sciences 856, 132–138.
Pan, W., Kastin, A.J. (1999) Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier, Advanced Drug Delivery Review 36, 291–298.
Goehler, L.E., Erisir, A., Gaykema, R.P. (2006) Neural-immune interface in the rat area postrema, Neuroscience 140, 1415–34.
Goehler, L.E., Lyte, M., Gaykema, R.P. (2007) Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology, Brain Behav Immun 21, 721–26.
Maier, S.F., Watkins, L.R. (1998) Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood and cognition, Psychological Review 105(1), 83–107.
Petitto, J.M., Huang, Z. (2001) Cloning the full-length IL-2/15 receptor-β cDNA sequence from mouse brain: evidence of enrichment in hippocampal formation neurons, Regulatory Peptides 98, 77–87.
Cunningham, E.T.J., Wada, E., Carter, D.B., Tracey, D.E., Battey, J.F., and De Souza, E.B. (1992) In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse, Journal of Neuroscience 12, 1101–1114.
Licinio, J., Wong, M.L., and Gold, P.W. (1991) Localization of interleukin-1 receptor antagonist mRNA in rat brain, Endocrinology 129, 562–564.
Schobitz, B., Voorhuis, D.A., De Kloet, E.R. (1992) Localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain, Neuroscience Letters 136, 189–192.
Lapchak, P.A. (1992) A role for interleukin-2 in the regulation of striatal dopaminergic function, Neuroreport 3, 165–168.
Petitto, J.M., Huang, Z. (1994) Molecular cloning of a partial cDNA of the interleukin-2 receptor-β in normal mouse brain: in situ localization in the hippocampus and expression by neuroblastoma cells, Brain Research 650, 140–145.
Petitto, J.M., Huang, Z., Raizada, M., Rinker, C.M., McCarthy, D.B. (1998) Molecular cloning of the cDNA coding sequence of IL-2 receptor-γ (γc) from human and murine forebrain: expression in the hippocampus in situ and by brain cells in vitro, Molecular Brain Research 53, 152–62.
Denicoff, K.D., Rubinow, D.R., Papa, M.Z., Simpson, C., Seipp, C.A., Lotze, M.T., Chang, A.E., Rosenstein, D., and Rosenberg, S.A. (1987) The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells, Annals of Internal Medicine 107, 293–300.
West, W.H., Tauer, K.W., Yannelli, J.R., Marshall, G.D., Orr, D.W., Thurman, G.B., and Oldham, R.K. (1987) Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer, New England Journal of Medicine 316, 898–905.
Capuron, L., Ravaud, A., Radat, F., Dantzer, R., Goodall, G. (1998) Effects of interleukin-2 and alpha interferon cytokine immunotherapy on the mood and cognitive performance of cancer patients, Neuroimmunomodulation 22, 9.
Eizenberg, O., Faber-Elman, A., Lotan, M. and Schwartz, M. (1995) Interleukin-2 Transcripts in Human and Rodent Brains: Possible Expression by Astrocytes, Journal of Neurochemistry 64, 1928–1936.
Lapchak, P.A., Araujo, D.M., Quirion, R., and Beaudet, A. (1991) Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain, Neuroscience 44, 173–184.
Villemain, F., Owens, T., Renno, T., Beaudet, A. (1991) Localization of mRNA for interleukin-2 (IL-2) in mouse brain by in situ hybridization, Soc. Neurosci. Abstr. 17, 1199.
Araujo, D.M., Lapchak, P.A. (1994) Induction of immune system mediators in the hippocampal formation in Alzheimer’s and Parkinson’s diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience 61, 745–754.
Hanisch, U.K., Quirion, R. (1996) Interleukin-2 as a neuroregulatory cytokine, Brain Research Reviews 21, 246–284.
Hanisch, U., Neuhaus, J., Rowe, W., Van-Rossum, D., Möller T., Kettenmann H., and Quirion, R. (1997) Neurotoxic consequences of central long-term administration of interleukin-2 in rats, Neuroscience 79, 799–818.
Labuzek, K., Kowalski, J., Gabryel, B., Herman, Z.S. (2005) Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures, Eur Neuropsychopharmacol 15, 23–30.
Awatsuji, H., Furukawa, Y., Nakajima, M., Furukawa, S., Hayashi, K. (1993) Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain, Journal of Neuroscience Research 35, 305–311.
Sarder, M., Saito, H., Abe, K. (1993) Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain, Brain Research 625, 347–350.
Sarder, M., Abe, K., Saito, H., Nishiyama, N. (1996) Comparative effect of IL-2 and IL-6 on morphology of cultured hippocampal neurons from fetal rat brain, Brain Research 715, 9–16.
Hanisch, U., Quirion, R. (1996) Interleukin-2 as a neuroregulatory cytokine, Brain Res. Rev. 21, 246–284.
Araujo, D.M., Lapchak, P.A., Collier, B., Quirion, R. (1989) Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system, Brain Res 498, 257–266.
Hanisch, U., Neuhaus, J., Rowe, W., Van-Rossum, D., Möller, T., Kettenmann, H., and Quirion, R. (1997) Neurotoxic consequences of central long-term administration of interleukin-2 in rats, Neurosci. 79, 799–818.
Hanisch, U.K., Seto, D., and Quirion, R. (1993) Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2, Journal of Neuroscience 13, 3368–3374.
Seto, D., Kar, S., Quirion, R. (1997) Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices, British journal of pharmacology 120, 1151–1157.
Tancredi, V., Zona, C., Velotti, F., Eusebi, F., Santoni, A. (1990) Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus, Brain Research 525, 149–151.
Bianchi, M., and Panerai, A.E. (1993) Interleukin-2 enhances scopolamine-induced amnesia and hyperactivity in the mouse, Neuroreport 4, 1046–1048.
Bianchi, M., Ferrario, P., Zonta, N., Panerai, A.E. (1995) Effects of interleukin-1 beta and interleukin-2 on amino acids levels in mouse cortex and hippocampus, Neuroreport 6, 1689–1692.
Mennicken, F., Quirion, R. (1997) Interleukin-2 increases choline acetyltransferase activity in septal-cell cultures, Synapse 26, 175–183.
Nemni, R., Iannaccone, S., Quattrini, A., Smirne, S., Sessa, M., Lodi, M., Erminio C., and Canal N. (1992) Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice, Brain Research 591, 248–252.
Lacosta, S., Merali, Z., Anisman, H. (1999) Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety, Behav Neurosci 113, 1030–1041.
Petitto, J.M., McNamara, R., Gendreau, P.L., Huang, Z., Jackson, A. (1999) Impaired learning and memory and altered hippocampal neurodevelopment resulting from IL-2 gene deletion, Journal of Neuroscience Research 56, 441–446.
Schöpke, R., Wolfer, D.P., Lipp, H.P., Leisinger-Trigona, M.C. (1991) Swimming navigation and structural variations of the infrapyramidal mossy fibers in the hippocampus of the mouse, Hippocampus 3, 315–28.
Schwegler, H., Crusio, W.E., Lipp, H.P., Heimrich, B. (1988) Water-maze learning in the mouse correlates with variation in hippocampal morphology, Behav Genet 18, 153–165.
Schwegler, H., Crusio, W.E. (1995) Correlations between radial-maze learning and structural variations of septum and hippocampus in rodents, Behav Brain Res 67, 29–41.
Beck, R.D., Jr., King, M.A., Ha, G.K., Cushman, J.D., Huang, Z., Petitto, J.M. (2005) IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins, J Neuroimmunol 160, 146–153.
Altman, J., Bayer, S.A. (1990) Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods, J Comp Neurol 301, 365–381.
Cameron, H.A., McKay, R.D. (2001) Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus, J Comp Neurol 435, 406–417.
Schwegler, H., Crusio, W.E., Lipp, H.P., Brust, I., Mueller, G.G. (1991) Early postnatal hyperthyroidism alters hippocampal circuitry and improves radial-maze learning in adult mice, J Neurosci 11, 2102–2106.
Alderson, R.F., Alterman, A.L., Barde, Y.A., Lindsay, R.M. (1990) Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture, Neuron 5, 297–306.
Morse, J.K., Wiegand, S.J., Anderson, K., You, Y., Cai, N., Carnahan, J., Miller, J., DiStefano, P.S., Altar, C.A., Lindsay, R.M., et al. (1993) Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection, J Neurosci 13, 4146–4156.
Ward, N.L., Hagg, T. (2000) BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo, Exp Neurol 162, 297–310.
Knipper, M., da Penha Berzaghi, M., Blochl, A., Breer, H., Thoenen, H., Lindholm, D. (1994) Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus, Eur J Neurosci 6, 668–67
Larsson, E., Mandel, R.J., Klein, R.L., Muzyczka, N., Lindvall, O., Kokaia, Z. (2002) Suppression of insult-induced neurogenesis in adult rat brain by brain-derived neurotrophic factor, Exp Neurol 177, 1–8.
Lee, J., Duan, W., Mattson, M.P. (2002) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice, J Neurochem 82, 1367–1375.
Besser, M., Wank, R. (1999) Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors, J Immunol 162, 6303–6306.
Canossa, M., Griesbeck, O., Berninger, B., Campana, G., Kolbeck, R., Thoenen, H. (1997) Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity, Proc Natl Acad Sci USA 94, 13279–13286.
Saarelainen, T., Vaittinen, S., Castren, E. (2001) trkB-receptor activation contributes to the kainate-induced increase in BDNF mRNA synthesis, Cell Mol Neurobiol 21, 429–435.
Beck, R.D., Jr., King, M.A., Huang, Z., Petitto, J.M. (2002) Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout, Brain Res 955, 16–23.
Hellweg, R., Humpel, C., Lowe, A., Hortnagl, H. (1997) Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes?, Brain Res Mol Brain Res 45, 177–181.
Hock, C., Heese, K., Hulette, C., Rosenberg, C., Otten, U. (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas, Arch Neurol 57, 846–851.
Merrill, J.E. (1990) Interleukin-2 effects in the central nervous system, Annals of the New York Academy of Sciences 594, 188–199.
Quirion, R., Aubert, I., Robitaille, Y., Gauthier, S., Araujo, D.M., Chabot, J.G. (1990) Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies, Clinical neuropharmacology 13, 73–80.
Zalcman, S.S. (2002) Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists, Brain research 944, 157–164.
Turka, L.A., Walsh, P.T. (2008) IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells, Front Biosci 13, 1440–1446.
Horak, I., Lohler, J., Ma, A., Smith, K.A. (1995) Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance, Immunological reviews 148, 35–44.
Kundig, T.M., Schorle, H., Bachmann, M.F., Hengartner, H., Zinkernagel, R.M., Horak, I. (1993) Immune responses in interleukin-2-deficient mice, Science 262, 1059–1061.
Schorle, H., Holtschke, T., Hunig, T., Schimpl, A., Horak, I. (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting, Nature 352, 621–624.
Kalman, J., Engelhardt, J.I., Le, W.D., Xie, W., Kovacs, I., Kasa, P., Appel, S.H. (1997) Experimental immune-mediated damage of septal cholinergic neurons, Journal of neuroimmunology 77, 63–74.
Beck, R.D., Jr., King, M.A., Ha, G.K., Cushman, J.D., Huang, Z., Petitto, J.M. (2005) IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins, Journal of neuroimmunology 160, 146–153.
Beck, R.D., Jr., King, M.A., Huang, Z., Petitto J.M. (2002) Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout, Brain research 955, 16–23.
Semba, K., Fibiger, H.C. (1988) Time of origin of cholinergic neurons in the rat basal forebrain, The Journal of comparative neurology 269, 87–95.
Acknowledgments
Funding for this study was provided by NIH RO1NS055018 and RO1NS048472.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Petitto, J.M., Huang, Z., Meola, D., Ha, G.K., Dauer, D. (2012). Interleukin-2 and the Septohippocampal System: Intrinsic Actions and Autoimmune Processes Relevant to Neuropsychiatric Disorders. In: Kobeissy, F. (eds) Psychiatric Disorders. Methods in Molecular Biology, vol 829. Humana Press. https://doi.org/10.1007/978-1-61779-458-2_27
Download citation
DOI: https://doi.org/10.1007/978-1-61779-458-2_27
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-457-5
Online ISBN: 978-1-61779-458-2
eBook Packages: Springer Protocols